Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation.
Marttila P, Bonagas N, Chalkiadaki C, Stigsdotter H, Schelzig K, Shen J, Farhat CM, Hondema A, Albers J, Wiita E, Rasti A, Warpman Berglund U, Slipicevic A, Mortusewicz O, Helleday T. Marttila P, et al. Among authors: chalkiadaki c. Mol Oncol. 2024 Mar 27. doi: 10.1002/1878-0261.13645. Online ahead of print. Mol Oncol. 2024. PMID: 38533616 Free article.
DNA Damage Estimation after Chronic and Combined Exposure to Endocrine Disruptors: An In Vivo Real-Life Risk Simulation Approach.
Karzi V, Ozcagli E, Tzatzarakis MN, Vakonaki E, Fragkiadoulaki I, Kalliantasi A, Chalkiadaki C, Alegakis A, Stivaktakis P, Karzi A, Makrigiannakis A, Docea AO, Calina D, Tsatsakis A. Karzi V, et al. Among authors: chalkiadaki c. Int J Mol Sci. 2023 Jun 10;24(12):9989. doi: 10.3390/ijms24129989. Int J Mol Sci. 2023. PMID: 37373136 Free PMC article.
Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells.
Green AC, Marttila P, Kiweler N, Chalkiadaki C, Wiita E, Cookson V, Lesur A, Eiden K, Bernardin F, Vallin KSA, Borhade S, Long M, Ghahe EK, Jiménez-Alonso JJ, Jemth AS, Loseva O, Mortusewicz O, Meyers M, Viry E, Johansson AI, Hodek O, Homan E, Bonagas N, Ramos L, Sandberg L, Frödin M, Moussay E, Slipicevic A, Letellier E, Paggetti J, Sørensen CS, Helleday T, Henriksson M, Meiser J. Green AC, et al. Among authors: chalkiadaki c. Nat Metab. 2023 Apr;5(4):642-659. doi: 10.1038/s42255-023-00771-5. Epub 2023 Apr 3. Nat Metab. 2023. PMID: 37012496 Free PMC article.
In Vivo Estimation of the Biological Effects of Endocrine Disruptors in Rabbits after Combined and Long-Term Exposure: Study Protocol.
Karzi V, Tzatzarakis MN, Alegakis A, Vakonaki E, Fragkiadoulaki I, Kaloudis K, Chalkiadaki C, Apalaki P, Panagiotopoulou M, Kalliantasi A, Kouretas D, Docea AO, Calina D, Tsatsakis A. Karzi V, et al. Among authors: chalkiadaki c. Toxics. 2022 May 12;10(5):246. doi: 10.3390/toxics10050246. Toxics. 2022. PMID: 35622659 Free PMC article.
Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin.
van Brunt K, Curtis B, Ivanyi T, Balogh E, Chalkiadaki C, MacLachlan S, Neasham D, Raluy-Callado M. van Brunt K, et al. Among authors: chalkiadaki c. Diabetes Ther. 2016 Dec;7(4):793-807. doi: 10.1007/s13300-016-0209-4. Epub 2016 Oct 31. Diabetes Ther. 2016. PMID: 27796906 Free PMC article.